Satsuma Pharmaceuticals Inc (STSA)
Aktien-Chart
Loading...
•
Kauf
•
Verkauf
•
Geplanter Kauf
•
Geplanter Verkauf
Netto-Kauf
Netto-Verkauf
Earnings
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | 2023-06-08 | K Kauf |
Shin Nippon Biomedical Laboratories, Ltd. Large shareholder |
8.423.732
+inf%
0,917.665.596 USD |
8.423.732 +inf% | 0,91 | 7.665.596 USD | |
| 2023-06-08 | 2023-06-06 | K Kauf |
Shin Nippon Biomedical Laboratories, Ltd. Large shareholder |
22.053.581
+inf%
0,9120.068.759 USD |
22.053.581 +inf% | 0,91 | 20.068.759 USD | |
| 2023-06-08 | 2023-06-06 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
22.053.581
+789.3%
0,9120.068.759 USD |
22.053.581 +789.3% | 0,91 | 20.068.759 USD | |
| 2022-11-23 | 2022-11-21 | K Kauf | Large shareholder |
150.000
+inf%
0,71106.740 USD |
150.000 +inf% | 0,71 | 106.740 USD | |
| 2022-11-16 | 2022-11-15 | K Kauf | Large shareholder |
300.694
+4.9%
0,63188.956 USD |
300.694 +4.9% | 0,63 | 188.956 USD | |
| 2022-11-16 | 2022-11-15 | K Kauf | Large shareholder |
531.000
+9.5%
0,63336.707 USD |
531.000 +9.5% | 0,63 | 336.707 USD | |
| 2022-11-16 | 2022-11-14 | K Kauf | Large shareholder |
5.608.306
+inf%
0,693.868.609 USD |
5.608.306 +inf% | 0,69 | 3.868.609 USD | |
| 2022-11-16 | 2022-11-14 | V Verkauf | Large shareholder |
3.250.000
-87.6%
0,712.294.500 USD |
3.250.000 -87.6% | 0,71 | 2.294.500 USD | |
| 2021-11-29 | 2021-11-24 | K Kauf | Large shareholder |
2.922
+0.1%
5,4215.837 USD |
2.922 +0.1% | 5,42 | 15.837 USD | |
| 2021-11-23 | 2021-11-22 | K Kauf | Large shareholder |
9.979
+0.3%
5,4954.785 USD |
9.979 +0.3% | 5,49 | 54.785 USD | |
| 2021-11-23 | 2021-11-19 | K Kauf | Large shareholder |
3.225
+0.1%
5,4417.544 USD |
3.225 +0.1% | 5,44 | 17.544 USD | |
| 2021-11-12 | 2021-11-11 | K Kauf | Large shareholder |
7.941
+0.2%
6,0548.043 USD |
7.941 +0.2% | 6,05 | 48.043 USD | |
| 2021-11-12 | 2021-11-10 | K Kauf | Large shareholder |
9.622
+0.3%
5,8556.289 USD |
9.622 +0.3% | 5,85 | 56.289 USD | |
| 2021-11-10 | 2021-11-08 | K Kauf | Large shareholder |
560
+0.0%
5,993.354 USD |
560 +0.0% | 5,99 | 3.354 USD | |
| 2021-11-08 | 2021-11-05 | K Kauf | Large shareholder |
7.800
+0.2%
5,9546.410 USD |
7.800 +0.2% | 5,95 | 46.410 USD | |
| 2021-11-08 | 2021-11-04 | K Kauf | Large shareholder |
1.400
+0.0%
5,888.232 USD |
1.400 +0.0% | 5,88 | 8.232 USD | |
| 2021-11-04 | 2021-11-02 | K Kauf | Large shareholder |
8.880
+0.2%
5,6450.083 USD |
8.880 +0.2% | 5,64 | 50.083 USD | |
| 2021-11-02 | 2021-10-29 | K Kauf | Large shareholder |
44.651
+1.2%
5,71254.957 USD |
44.651 +1.2% | 5,71 | 254.957 USD | |
| 2021-10-29 | 2021-10-28 | K Kauf | Large shareholder |
15.082
+0.4%
5,5583.705 USD |
15.082 +0.4% | 5,55 | 83.705 USD | |
| 2021-10-29 | 2021-10-27 | K Kauf | Large shareholder |
39.581
+1.1%
5,45215.716 USD |
39.581 +1.1% | 5,45 | 215.716 USD | |
| 2021-10-25 | 2021-10-22 | K Kauf | Large shareholder |
27.629
+0.8%
5,51152.236 USD |
27.629 +0.8% | 5,51 | 152.236 USD | |
| 2021-10-25 | 2021-10-21 | K Kauf | Large shareholder |
32.816
+0.9%
5,40177.206 USD |
32.816 +0.9% | 5,40 | 177.206 USD | |
| 2021-10-21 | 2021-10-20 | K Kauf | Large shareholder |
40.663
+1.2%
5,44221.207 USD |
40.663 +1.2% | 5,44 | 221.207 USD | |
| 2021-10-21 | 2021-10-19 | K Kauf | Large shareholder |
87.580
+2.6%
5,07444.031 USD |
87.580 +2.6% | 5,07 | 444.031 USD | |
| 2021-10-19 | 2021-10-18 | K Kauf | Large shareholder |
36.194
+1.1%
4,87176.265 USD |
36.194 +1.1% | 4,87 | 176.265 USD | |
| 2021-10-19 | 2021-10-15 | K Kauf | Large shareholder |
126.000
+3.9%
4,83608.580 USD |
126.000 +3.9% | 4,83 | 608.580 USD | |
| 2021-03-02 | 2021-02-26 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied Large shareholder |
1.232.394
+31.4%
5,686.999.998 USD |
1.232.394 +31.4% | 5,68 | 6.999.998 USD | |
| 2020-09-03 | 2020-09-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.000
-4.7%
22,2122.210 USD |
1.000 -4.7% | 22,21 | 22.210 USD | |
| 2020-09-03 | 2020-09-01 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
750
-100.0%
22,1916.645 USD |
750 -100.0% | 22,19 | 16.645 USD | |
| 2020-08-07 | 2020-08-05 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
1.000
-100.0%
25,0025.000 USD |
1.000 -100.0% | 25,00 | 25.000 USD | |
| 2020-08-05 | 2020-08-03 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
200
-1.0%
23,124.624 USD |
200 -1.0% | 23,12 | 4.624 USD | |
| 2020-08-05 | 2020-08-03 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
800
-3.8%
22,8518.282 USD |
800 -3.8% | 22,85 | 18.282 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
100
-0.5%
27,812.781 USD |
100 -0.5% | 27,81 | 2.781 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
600
-2.9%
26,9916.195 USD |
600 -2.9% | 26,99 | 16.195 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
300
-1.5%
25,697.707 USD |
300 -1.5% | 25,69 | 7.707 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
306
-100.0%
27,598.444 USD |
306 -100.0% | 27,59 | 8.444 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
394
-100.0%
26,7010.520 USD |
394 -100.0% | 26,70 | 10.520 USD | |
| 2020-07-02 | 2020-07-01 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
300
-100.0%
25,637.690 USD |
300 -100.0% | 25,63 | 7.690 USD | |
| 2020-06-24 | 2020-06-23 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
2.115
-100.0%
35,2374.512 USD |
2.115 -100.0% | 35,23 | 74.512 USD | |
| 2020-06-02 | 2020-06-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.000
-4.7%
25,2625.257 USD |
1.000 -4.7% | 25,26 | 25.257 USD | |
| 2020-06-02 | 2020-06-01 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
1.000
-100.0%
25,3225.324 USD |
1.000 -100.0% | 25,32 | 25.324 USD | |
| 2020-05-21 | 2020-05-20 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
2.000
-100.0%
25,0050.000 USD |
2.000 -100.0% | 25,00 | 50.000 USD | |
| 2020-05-06 | 2020-05-05 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.000
-4.7%
20,0020.000 USD |
1.000 -4.7% | 20,00 | 20.000 USD | |
| 2020-04-16 | 2020-04-14 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
800
-3.8%
20,0016.000 USD |
800 -3.8% | 20,00 | 16.000 USD | |
| 2020-04-03 | 2020-04-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
200
-1.0%
20,254.049 USD |
200 -1.0% | 20,25 | 4.049 USD | |
| 2020-03-12 | 2020-03-11 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.000
-4.7%
27,4227.422 USD |
1.000 -4.7% | 27,42 | 27.422 USD | |
| 2020-03-12 | 2020-03-11 | GV Geplanter Verkauf |
Chief Financial Officer Führungsperson |
1.000
-100.0%
27,6827.678 USD |
1.000 -100.0% | 27,68 | 27.678 USD | |
| 2019-09-18 | 2019-09-17 | K Kauf |
TPG Group Holdings (SBS) Advisors, Inc. Large shareholder |
100.000
+5.6%
15,001.500.000 USD |
100.000 +5.6% | 15,00 | 1.500.000 USD | |
| 2019-09-17 | 2019-09-17 | K Kauf |
233.333
+17.6%
15,003.499.995 USD |
233.333 +17.6% | 15,00 | 3.499.995 USD | ||
| 2019-09-17 | 2019-09-17 | K Kauf | Large shareholder |
192.387
+4.3%
15,002.885.805 USD |
192.387 +4.3% | 15,00 | 2.885.805 USD | |
| 2019-09-17 | 2019-09-17 | K Kauf | Large shareholder |
1.140.946
+34.1%
15,0017.114.190 USD |
1.140.946 +34.1% | 15,00 | 17.114.190 USD | |
| 2019-09-17 | 2019-09-17 | K Kauf | Large shareholder |
1.333.333
+39.8%
15,0019.999.995 USD |
1.333.333 +39.8% | 15,00 | 19.999.995 USD |